Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

AstraZeneca UK Limited
Horizon Place, 600 Capability Green, Luton, Bedfordshire, LU1 3LU
Telephone: +44 (0)1582 836 000
Fax: +44 (0)1582 838 000
Medical Information Direct Line: +44 (0)1582 836 836
Medical Information e-mail: medical.informationuk@astrazeneca.com
Customer Care direct line: +44 (0)1582 837 837
Medical Information Fax: +44 (0)1582 838 003

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 24/12/2010
PIL Bricanyl Injection, 0.5 mg/ml, solution for injection or infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 24/12/2010 and displayed until Current
Reasons for adding or updating:
  • Change of manufacturer
Updated on 08/04/2009 and displayed until 24/12/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 21/10/2008 and displayed until 08/04/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 26/07/2004 and displayed until 21/10/2008
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 04/09/2002 and displayed until 26/07/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 14/09/2000 and displayed until 04/09/2002
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  terbutaline sulphate